Announcement Nona Biosciences, a leading biotechnology company thoroughly modernising the discovery pathway via innovative technology platforms have now extended its unified development and exploratory framework to contribute largely to Investigator-Initiated Trials (IITs) and early clinical develo...
Announcement Italfarmaco S.p.A and JCR Pharmaceuticals Co., Ltd. excitedly announced their exclusive licensing agreement for the marketing and development of givinostat in Japan. Alongside, both companies are in collaboration for rare disease area as well. Terms of the strategic deal According to...
Announcement Mabwell, a leading innovation enthusiast biopharmaceutical company with a fully unified industry chain, has declared that it has received clearance from the U.S. Food and Drug Administration (FDA) for its own established anti-ST2 monoclonal antibody to begin with a Phase 2a clinical st...
Announcement The China-based Innovent Biologics, Inc., a leading biopharmaceutical company that focuses on establishing, manufacturing, and marketing quality-standard medicines for curing autoimmune, cardiovascular, oncology, ophthalmology, metabolic, and other critical conditions, has announced ap...
Milestone CancerVax, Inc., a leading developer of a groundbreaking Universal Cancer Treatment Platform that treats cancer through the body’s immune system, revealed its year end overview, spotlighting the meaningful advancements the success achieved throughout 2025. This is like a celebration...
Announcement Phio Pharmaceuticals Corp., a well-known clinical-level siRNA biopharmaceutical company discovering therapeutics with its exclusive INTASYL® gene mutation technology to treat cancer. The company has announced that it has taken a crucial step in its drug development program for PH-7...
Announcement IRLAB Therapeutics AB, a leading company aimed on developing and exploring new treatments for Parkinson’s disease, announced that it has received a green signal for its Phase IB study of IRL757 to evaluate tolerability, signal and safety findings in Parkinson’s patients who...
Announcement Next Gen Diagnostics announced the exciting offshoot of its Infection Prevention division into an independent and strong-headed company from 1st January 2026. The company will be called as NGD Infection Prevention aimed on the execution of real-time, on-point genomic transmission detec...
Announcement Samsung Biologics, a popular contract development and manufacturing organisation (CDMO), has declared that Samsung Biologics America, a fully owned U.S subsidiary, has signed a definitive deal to procure full Human Genome Sciences (HGS) from GSK. This smart strategy will protect Samsun...
Announcement Ipsen, a French-based biopharmaceutical company concentrating on marketing and drug development in neuroscience, rare disease and oncology spaces, has proudly revealed its exclusive licensing agreement for its SIM0613, an antibody-drug conjugate (ADC), to gain universal rights in Great...
